mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
2e-08 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
5e-06 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
0.23 |
1e-05 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
1e-05 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-05 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
0.21 |
4e-05 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
7e-05 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
9e-05 |